ArticleTranslational oncology2013

(18)F-FDG Is a Surrogate Marker of Therapy Response and Tumor Recovery after Drug Withdrawal during Treatment with a Dual PI3K/mTOR Inhibitor in a Preclinical Model of Cisplatin-Resistant Ovarian Cancer.

Stéphanie Lheureux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.